Cancer–neuronal crosstalk and the startups working to silence it
Elie Dolgin • February 7, 2020
Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.
Continue reading here.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.